Product Images Asenapine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 16 images provide visual information about the product associated with Asenapine NDC 59762-1091 by Greenstone Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a table displaying the effects (inhibitor or inducer) of various substances on different enzymes, based on their Cmax and AUC values. The enzymes mentioned include CYPIAZ, CYPIAZAC, CYRD6, CYPIALADNIAL, CYP3AY and UGTIAG. It is unclear what the numbers in the last row represent as the text is cut off.*
This text describes the effects of Ascnapine on the metabolism of Paroxetine and Imipramine in healthy individuals. Ascnapine appears to be a weak inhibitor of CYP206, which is a marker of CYP2D6 activity. Treatment with Ascnapine decreased the DX/DA ratio indicating CYP2D6 inhibition. Paroxetine treatment also decreased the DX/DM ratio. Co-administration of a single 75 mg dose of Imipramine with a single 3 mg dose of Ascnapine did not affect the plasma concentrations of the metabolite Desipramine which is a CYP2D6 substrate. The text provides information on the substrates and inhibitors for CYP2D6, CYP1A2, CYP19/3A4, and their effects on AUC and Cmax.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.